duoABLE for People With Stroke and Their Caregivers

Sponsor
University of Minnesota (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05964400
Collaborator
American Occupational Therapy Foundation (Other)
40
1
1
8
5

Study Details

Study Description

Brief Summary

The goal of this intervention study is to test whether a behavioral program that involves people with stroke and their caregivers is acceptable, safe, and can promote physically active lifestyles using enjoyable activities. Participant duos (person with stroke and their caregiver) will be asked to complete assessments at 2 timepoints, wear an activity tracker, participate in 12 sessions with an occupational therapist, and complete an interview.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: duoABLE
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
duoABLE for People With Stroke and Their Caregivers (Feasibility)
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: duoABLE

Stroke participant-caregiver duos (dyads) will meet with an occupational therapist 12 times (2x/week for 6 weeks, approximately 30 minutes/session) to apply activity monitoring, activity scheduling, collaborative problem solving, self-assessment, and social interdependence to self-selected activities that aim to increase both dyad members' physical activity levels

Behavioral: duoABLE
Stroke participant-caregiver duos (dyads) will meet with an occupational therapist 12 times (2x/week for 6 weeks, approximately 30 minutes/session) to apply activity monitoring, activity scheduling, collaborative problem solving, self-assessment, and social interdependence to self-selected activities that aim to increase both dyad members' physical activity levels

Outcome Measures

Primary Outcome Measures

  1. Participant satisfaction [Score at week 8]

    Measured using the Client Satisfaction Questionnaire-8 (CSQ-8)

Secondary Outcome Measures

  1. Change in activity restrictions [Baseline to 8 weeks]

    Proportion of activities retained assessed at baseline and 8-weeks by the Activity Card Sort 3

  2. Change in sedentary minutes per day [Baseline to 8 weeks]

    Minutes of sedentary time per day, measured using the activPAL micro4 (mean minutes per day determined by 7-day wear protocol) at baseline and week 8.

  3. Change in daily step count [Baseline to 8 weeks]

    Count of steps per day, measured using the activPAL micro4 (mean daily step count determined by 7-day wear protocol) at baseline and week 8.

  4. Change in Health-related quality of life [Baseline to 8 weeks]

    Change in score on the EuroQoL-5 Dimensions-5 Levels (EQ-5D-5L) measured at baseline and week 8

  5. Adverse event count [Count of adverse events at week 8]

    Total count of adverse events over the course of the study based on an adverse events questionnaire completed at 8 weeks

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria (Stroke Participants):
  • Stroke diagnosed more than 6 months ago

  • Are 18 years of age or older

  • Report ≥6 hours of sedentary behavior on a typical day OR report engagement in ≤90 minutes of moderate-to-vigorous physical activity in the past week

  • Reside in a community-based setting

  • Are mobile within their home, with or without an assistive device and without physical assistance

  • Are able to identify an eligible caregiver who will engage in assessments and intervention.

Inclusion Criteria (Caregiver Participants):
  • Are 18 years of age or older

  • Report ≥6 hours of sedentary behavior on a typical day OR report engagement in ≤90 minutes of moderate-to-vigorous physical activity in the past week

  • Reside in a community-based setting

  • Are mobile within their home, with or without an assistive device and without physical assistance

Exclusion Criteria (Stroke Participants):
  • Severe aphasia

  • Are currently receiving chemotherapy or radiation treatments for cancer

  • Have a medical diagnosis of neurodegenerative disorder (i.e., dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, glioblastoma)

  • Received inpatient treatment for substance use disorder or psychiatric condition within the past 12 months

  • Have a history of skin sensitivity related to adhesives

  • Are pregnant or expecting to become pregnant in the next 2 months

  • Reside in an institutional setting

  • Are currently incarcerated

Exclusion Criteria (Caregiver Participants):
  • Have a history of skin sensitivity related to adhesives

  • Are currently receiving chemotherapy or radiation treatments for cancer

  • Have a medical diagnosis of neurodegenerative disorder (i.e., dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, glioblastoma)

  • Received inpatient treatment for substance use disorder or psychiatric condition within the past 12 months

  • Are pregnant or expecting to become pregnant in the next 2 months

  • Reside in an institutional setting

  • Are currently incarcerated

Contacts and Locations

Locations

Site City State Country Postal Code
1 School of Kinesiology, University of Minnesota Minneapolis Minnesota United States 55455

Sponsors and Collaborators

  • University of Minnesota
  • American Occupational Therapy Foundation

Investigators

  • Principal Investigator: Emily A Kringle, PhD, OTR/L, University of Minnesota

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Minnesota
ClinicalTrials.gov Identifier:
NCT05964400
Other Study ID Numbers:
  • duoABLE
  • AOTFIRG23KRINGLE
First Posted:
Jul 27, 2023
Last Update Posted:
Jul 27, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Minnesota
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2023